Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
less decrease » we decrease (Expand Search), levels decreased (Expand Search), largest decrease (Expand Search)
Showing 661 - 680 results of 5,288 for search 'significantly ((((less decrease) OR (((teer decrease) OR (greater decrease))))) OR (mean decrease))', query time: 0.34s Refine Results
  1. 661
    Test soil parameters.

    Test soil parameters. by Yonggang Huang (223155)

    Published 2025
    “…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”
    Save to List
    Saved in:
  2. 662
    Influence of UHMWPE length on swelling pressure.

    Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    “…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”
    Save to List
    Saved in:
  3. 663
    UHMWPF parameters.

    UHMWPF parameters. by Yonggang Huang (223155)

    Published 2025
    “…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”
    Save to List
    Saved in:
  4. 664
    Influence of UHMWPE content on swelling pressure.

    Influence of UHMWPE content on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    “…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”
    Save to List
    Saved in:
  5. 665
    Soil partice-size distribution.

    Soil partice-size distribution. by Yonggang Huang (223155)

    Published 2025
    “…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …”
    Save to List
    Saved in:
  6. 666
    Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults).

    Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults). by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 667
    Correlation and median comparison. ACE2 and TMPRSS2 expression.

    Correlation and median comparison. ACE2 and TMPRSS2 expression. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 668
    Correlation between age and ACE2ACE2 and TMPRSS2 protease expression.

    Correlation between age and ACE2ACE2 and TMPRSS2 protease expression. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 669
    Summary of study participants.

    Summary of study participants. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 670
    Most common symptoms and frequency of appearance among IgG-positive patients.

    Most common symptoms and frequency of appearance among IgG-positive patients. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 671
    Age difference between patients with negative and positive serologic results in adults(a) and children(b).

    Age difference between patients with negative and positive serologic results in adults(a) and children(b). by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 672
    Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression.

    Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 673
    Correlation between age and antibody indexes in both children and adults.

    Correlation between age and antibody indexes in both children and adults. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 674
    The interaction of ACE2 and TMPRSS2 with SARS-CoV-2.

    The interaction of ACE2 and TMPRSS2 with SARS-CoV-2. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 675
    Participants’ characteristics.

    Participants’ characteristics. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 676
    Sources of infection.

    Sources of infection. by Jesús Poch-Páez (21807825)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 677
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 678
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 679
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 680
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: